Medical Diagnosis » E » Erythema multiforme

Medical Diagnosis
Search
» A
» B
» C
» D
» E
» F
» G
» H
» I
» J
» K
» L
» M
» N
» O
» P
» Q
» R
» S
» T
» U
» V
» W
» Y
» Z
 

Erythema multiforme

 
 

Erythema multiforme


OVERVIEW:

Erythema multiforme (EM) is an acute self limited hypersensitivity reaction involving the skin and sometimes the mucus membranes. Erythema multiforme minor- also called the erythema multiforme - Hebra, is a mild form appearing as a pleomorphic rash which includes target lesions, but not large vesicles or petechia, affecting the skin with or without involving one mucus membrane site. Erythema multiforme major is a more severe form, involving more than one mucus membrane site. It was formerly considered to be the same as Stevens-Johnson syndrome, but is now believed to be unrelated.

System(s) affected: Skin/exocrine
Genetics: Possibly associated with HLA-B15
Incidence/Prevalence in USA: Not known. In Germany the incidence of erythema multiforme major, Stevens Johnson syndrome and toxic epidermal necrolysis combined appears to be 1.89 per million persons per year.
Predominant age: Peak incidence in 20's and 30's; rare under 3 and over age 50
Predominant sex: Male > Female (3:2)

SIGNS AND SYMPTOMS:

• The typical pleomorphic eruption is a mixture of macules of various sizes and target lesions. These consist of a central inflamed and superficially necrotic area, surrounded by a halo of less inflamed skin, enclosed within an outer erythematous rim. Purpuric lesions are uncommon, and vesicles may be related to antecedent herpes I infections. The rash occurs on the palms, soles, dorsum of the hands and extensor surface of the extremities and the face. It is often recurrent, following a viral infection.
• Involvement of the mucus membranes is quite common, which caused confusion with Stevens Johnson syndrome. In EM mucus membrane involvement consists of target lesions of the lips or herpetic lesions without extensive necrosis.
• Pruritus is usually absent
• The skin may feel normal, or there may be a mild burning sensation.
• If corneal ulceration occurs it is a serious complication

CAUSES:

• Most cases appear to be due to a preceding infection. Drugs seem to be an infrequent cause.
• Viral infections - particularly herpes simplex; also Epstein-Barr, Coxsackie, echovirus, varicella, mumps and poliovirus
• Bacterial infections- including Brucellosis, diphtheria (etc.), borreliosis. Mycoplasma appears to more often precede Stevens-Johnson syndrome.
• Protozoan infections
• Fungal infection, including Trichophyton rubrum
• Collagen vascular diseases
• Malignancy
• Pregnancy
• Premenstrual hormone changes
• Consumption of beer
• Reiter's syndrome
• Sarcoidosis
• Vaccines- tetanus/diphtheria (Td), bacillus Calmette-Guerin (BCG), oral polio vaccine (OPV)
• Medications- the accepted list includes sulfonamides, penicillins, anticonvulsants, salicylates, but many of these were actually associated with Stevens Johnson syndrome when it was considered to be a type of erythema nodosum major
• Radiotherapy

RISK FACTORS:

• Previous history of erythema multiforme
• Male sex

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS:

• Stevens Johnson syndrome
• Urticaria
• Necrotizing vasculitis
• Drug eruptions
• Contact dermatitis
• Pityriasis rosea
• Secondary syphilis
• Ringworm
• Pemphigus vulgaris
• Pemphigoid
• Dermatitis herpetiformis
• Herpes gestationis
• Septicemia
• Serum sickness
• Viral exanthems
• Rocky Mountain spotted fever
• Collagen vascular diseases
• Mucocutaneous lymph node syndrome
• Meningococcemia
• Lichen planus
• Behcet's syndrome
• Recurrent aphthous ulcers
• Herpetic gingivostomatitis
• Granuloma annulare

LABORATORY:

None

Drugs that may alter lab results: N/A
Disorders that may alter lab results: N/A

PATHOLOGICAL FINDINGS:

A predominantly inflammatory pattern characterized by a lichenoid infiltrate which is of high density and rich in T-lymphocytes, and epidermal necrosis that mainly affects the basal layer

SPECIAL TESTS:

N/A

IMAGING:

N/A

DIAGNOSTIC PROCEDURES:

Skin biopsy

TREATMENT

APPROPRIATE HEALTH CARE:

Care at home, unless mouth herpes precludes oral intake.

GENERAL MEASURES:

• Treatment of any underlying or causative disease
• Withdrawal of any causative drugs
• For mild cases, symptomatic treatment is sufficient. For more severe cases, meticulous wound care and use of Burow's solution or Domeboro solution dressings.
• Oral lesions can be treated with mouthwashes with warm saline, or a solution of diphenhydramine, lidocaine (Xylocaine), and Kaopectate to provide symptomatic relief and oral hygiene, and to facilitate oral intake

SURGICAL MEASURES:

N/A

ACTIVITY:

As tolerated

DIET:

As tolerated with increased fluid intake

PATIENT EDUCATION:

Patients should be reassured that the disease is self-limited. Recurrences are possible. Encourage avoidance of any identified etiologic agent.

MEDICATIONS

DRUG(S) OF CHOICE:

The use of steroids is controversial. Patients who have herpes induced EM may benefit from acyclovir, and those who take acyclovir between episodes of recurrent herpetic EM get fewer episodes. Other causative infections should be treated. appropriately.

Contraindications: Some underlying infections or health problems such as diabetes may contraindicate the use of steroids
Precautions: Refer to manufacturer's profile of each drug
Significant possible interactions: Refer to manufacturer's profile of each drug

ALTERNATIVE DRUGS:

None have been shown to be useful

FOLLOW UP

PATIENT MONITORING:

The disease is self limiting. Complications are rare. There is no mortality.

PREVENTION/AVOIDANCE:

• Known or suspected etiologic agents should be avoided
• Acyclovir may help prevent herpes-related erythema multiforme
• Tamoxifen has been shown to prevent premenstrual related disease

POSSIBLE COMPLICATIONS:

Corneal ulceration is a serious complication of Stevens-Johnson syndrome. It is not clear whether this can occur in true EM. While there may be complications of the underlying disease, there are no other complications of EM.

EXPECTED COURSE AND PROGNOSIS:

• Rash evolves over 1-2 weeks and subsequently resolves within 2-3 weeks, generally without scarring or sequelae
• Following resolution there may be some post-inflammatory hyperpigmentation
• Risk of recurrence may be as high as 37%

MISCELLANEOUS

ASSOCIATED CONDITIONS:

Any of the infections or diseases listed under causes.

AGE-RELATED FACTORS:


Pediatric: More severe forms of the disease tend to occur in younger males. Rare under age 3 years.
Geriatric: Rare over age 50 years
Others: N/A

PREGNANCY:

Reported as a possible etiologic condition

SYNONYMS:

Erythema exudativum multiforme

ICD-9-CM:

695.1 erythema multiforme

(see images)




Want to discuss this term? Visit our forum or our chat room.

SEE ALSO (Enter the keywords below into our search box or click on the link):

n/a


Google
  Web medfamily.org

 
 
 
 

Total Medical Terms: 37

« 17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32 33  34  35  36  37  »
Rate this site!


COPYRIGHT © 2001 - 2004 Medical Diagnosis

Joint Partnership with
Care Earth | SGU Community | Solo Futbol | TUMS-Ped | Med Family | Med School Chat | Law School Chat

part of the School Chat Network. All Rights Reserved. Hosted by My Crazy Cheap Hosting.
MSC: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15. By viewing this website, you agree to our disclaimer.
Cheap Medical Books | Cheap USMLE Books | Cheap MCAT Books | Cheap Books | Cheap Store

We're still here, you rockin' with the best!
Best View with 1024x768 screen and IE 5.0
Disclaimer: Although the medFamily materials have been developed by physicians and health care provider it is designed for educational purposes only. The site is not engaged in rendering medical advice. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. It is solely for information and second opinion purposes. If you have or suspect you may have a health problem, you should consult your health care provider and use the information here as a cross references. The authors, editors, producers, sponsors, and contributors shall have no liability, obligation or responsibility to any person or entity for any loss, damage, or adverse consequence alleged to have happened directly or indirectly as a consequence of this material.